GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a remarkable shift in how we treat type 2 diabetes . These new drugs function to mimicking the body’s own GLP-1 process, which promotes https://tripsbookmarks.com/story21771053/glp-1-a-significant-approach-in-blood-sugar-management